EEA1 抗体 (AA 264-309)
Quick Overview for EEA1 抗体 (AA 264-309) (ABIN2886353)
抗原
See all EEA1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 264-309
- 
                                            特异性
- Human EEA1
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide, corresponding to amino acids 264-309 of Human EEA1.
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.2, 15 mM sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid freeze-thaw cycles.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - EEA1 (Early Endosome Antigen 1 (EEA1))
- 
                                            别名
- EEA1
- 
                                            背景
- 
                        Name/Gene ID: EEA1
 Synonyms: EEA1, MST105, MSTP105, ZFYVE2, Early endosome antigen 1
- 
                                            基因ID
- 8411
- 
                                            途径
- Toll-Like Receptors Cascades
 抗原
- 
                    
 
                                     
                                     
                                    